Eukles Asset Management Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management trimmed its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the period. Eukles […]

Related Keywords

United States ,Patricia Carr ,Piper Sandler ,Stifel Nicolaus ,Philipl Johnson ,Covestor Ltd ,Jazz Pharmaceuticals Price Performance ,News Ratings For Jazz Pharmaceuticals Daily ,Insider Activity At Jazz Pharmaceuticals ,Quarter For Jazz Pharmaceuticals ,Needham Company ,Cantor Fitzgerald ,Jazz Pharmaceuticals ,Nasdaq ,Headlands Technologies ,Securities Exchange Commission ,Jazz Pharmaceuticals Profile ,Eukles Asset Management ,Free Report ,Asset Management ,Wealth Management ,Get Free Report ,Exchange Commission ,Visit Holdingschannel ,Jazz Pharmaceuticals Daily ,